1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
21.43 -1.26 (-5.55%)
1.7M
XNAS Volume

XNAS 08 Aug, 2025 5:30 PM (EDT)

Board Meeting
The latest board meeting for Genmab - ADR took place on 08 Aug 2025, for the purpose of Genmab A/S Second Quarter Earnings Results for 2025 See details

Genmab - ADR - GMAB - stock price prediction, stock price target, analyst ratings from 9 analysts

Genmab - ADR has a share price target of US$ 30, revenue growth forecast of 19.9%, and profit growth estimate of -5.5% for FY25, based on top 9 analyst calls.